SymBiosis Capital Partners, LLC

Position in IVA — Inventiva S.A.

CIK 2006045 BENTONVILLE, AR

Position in IVA

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$13,064,700

+$974,700 QoQ

Shares Held

2,354,000

-9.5% QoQ

Ownership

0.997%

of shares outstanding

% of Portfolio

24.76%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SymBiosis Capital Partners, LLC holds $50,642,960 across 4 Biotechnology names. IVA ranks #2 (25.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EVMN	Evommune, Inc.	1,280,778	$29,445,086
2	IVA	Inventiva S.A. This page	2,354,000	$13,064,700
3	WVE	Wave Life Sciences Ltd.	750,000	$5,437,500
4	RANI	Rani Therapeutics Holdings, Inc.	3,667,585	$2,695,674

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$13,064,700	2,354,000	-9.5%	Shares	Sole	2026-05-12
2025-12-31	$12,090,000	2,600,000	—	Shares	Sole	2026-02-12
No filing history on record for this holder in this stock.